- Home
- BDSX vs SRG Comparison
BDSX vs SRG Comparison
Compare BDSX & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- SRG
- Stock Information
- Founded
- BDSX 2005
- SRG 2014
- Country
- BDSX United States
- SRG United States
- Employees
- BDSX N/A
- SRG N/A
- Industry
- BDSX Precision Instruments
- SRG Real Estate Investment Trusts
- Sector
- BDSX Health Care
- SRG Real Estate
- Exchange
- BDSX Nasdaq
- SRG Nasdaq
- Market Cap
- BDSX 194.9M
- SRG 238.6M
- IPO Year
- BDSX 2020
- SRG 2015
- Fundamental
- Price
- BDSX $1.51
- SRG $4.09
- Analyst Decision
- BDSX Strong Buy
- SRG
- Analyst Count
- BDSX 4
- SRG 0
- Target Price
- BDSX $3.08
- SRG N/A
- AVG Volume (30 Days)
- BDSX 332.5K
- SRG 283.5K
- Earning Date
- BDSX 11-01-2024
- SRG 11-12-2024
- Dividend Yield
- BDSX N/A
- SRG N/A
- EPS Growth
- BDSX N/A
- SRG N/A
- EPS
- BDSX N/A
- SRG N/A
- Revenue
- BDSX $65,562,000.00
- SRG $56,359,000.00
- Revenue This Year
- BDSX $46.97
- SRG N/A
- Revenue Next Year
- BDSX $30.43
- SRG N/A
- P/E Ratio
- BDSX N/A
- SRG N/A
- Revenue Growth
- BDSX 48.92
- SRG N/A
- 52 Week Low
- BDSX $1.11
- SRG $3.63
- 52 Week High
- BDSX $2.21
- SRG $9.87
- Technical
- Relative Strength Index (RSI)
- BDSX 48.94
- SRG 40.43
- Support Level
- BDSX $1.24
- SRG $3.97
- Resistance Level
- BDSX $1.43
- SRG $4.55
- Average True Range (ATR)
- BDSX 0.10
- SRG 0.15
- MACD
- BDSX 0.01
- SRG -0.04
- Stochastic Oscillator
- BDSX 64.44
- SRG 19.31
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management and leasing of diversified and mixed-use properties throughout the United States.